$6.49 -0.04 (-0.61%)
2/10/2012 4:00 PM

DepoMed, Inc. (NASDAQ:DEPO)

CAPS Rating: 3 out of 5

A specialty pharmaceutical company focused on the development and commercialization of differentiated products that address growing markets and are based on proprietary oral drug delivery technologies.

Featured Broker Partners


Advertisement